Nanobiose provides innovative solutions to increase the relevance and predictive power of complex in vitro models.

Our ambition is to improve the in vitro assessment of drug candidates, to accelerate time to market, reduce costs of development and the use of laboratory animals and finally get more and safer drugs on the market.